RiverPark Advisors’s Elevance Health ELV Stock Holding History

RiverPark Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,300	Closed	-$786K	–	56
2018 Q2	$786K	Sell	3,300 -2,900	-47%	-$672K	0.16%	63
2018 Q1	$1.36M	Sell	6,200 -800	-11%	-$188K	0.26%	62
2017 Q4	$1.57M	Hold	7,000	–	–	0.23%	60
2017 Q3	$1.33M	Hold	7,000	–	–	0.18%	63
2017 Q2	$1.32M	Hold	7,000	–	–	0.15%	65
2017 Q1	$1.16M	Sell	7,000 -1,800	-20%	-$286K	0.08%	67
2016 Q4	$1.26M	Buy	+8,800	New	+$1.18M	0.67%	51

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RiverPark Advisors's ELV Position: Q3 2018 in Review

RiverPark Advisors sold out of Elevance Health (ELV) in Q3 2018, closing a stake of 3,300 shares — an estimated $786K sold.

RiverPark Advisors first reported a position in ELV in Q4 2016 and held it in 7 quarters. The position peaked at $1.57M in Q4 2017. 945 funds tracked by Wall St. Rank hold ELV as of Q3 2018.

RiverPark Advisors reported no remaining Elevance Health position as of Q3 2018 after selling out during the quarter.
RiverPark Advisors sold 3,300 Elevance Health shares in Q3 2018, an estimated $786K.
RiverPark Advisors first reported a position in Elevance Health in Q4 2016 and held it in 7 quarters.
RiverPark Advisors's Elevance Health position peaked at $1.57M in Q4 2017.
945 funds tracked by Wall St. Rank held Elevance Health as of Q3 2018.

Based on RiverPark Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.